Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease. // Biochimica et Biophysica Acta: Proteins and Proteomics. – URL: https://www.sciencedirect.com/science/article/pii/S1570963926000543?dgcid=rss_sd_all
Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease. Biochimica et Biophysica Acta: Proteins and Proteomics. https://www.sciencedirect.com/science/article/pii/S1570963926000543?dgcid=rss_sd_all
“Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease.” Biochimica et Biophysica Acta: Proteins and Proteomics.
@article{article93293,
title = {Indoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease},
journal = {Biochimica et Biophysica Acta: Proteins and Proteomics},
url = {https://www.sciencedirect.com/science/article/pii/S1570963926000543?dgcid=rss_sd_all}
}